IDEAYA Biosciences (IDYA) Net Margin (2020 - 2026)
IDEAYA Biosciences' Net Margin came in at -1269.64% for Q2 2026, up 232.48 percentage points from the prior quarter.
Powered by 
Analysis
IDEAYA Biosciences (IDYA) Net Margin (2020 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, IDEAYA Biosciences reported Net Margin of -74.75%; for FY2025, it was -51.99%, up 3869.11 percentage points from FY2024.
- Net Margin carries a five-year change of +124.57 percentage points (FY2020 to FY2025).
- Going back by year, Net Margin was -3921.10% in FY2024 (-3438.05 pp), -483.05% in FY2023 (-367.88 pp), -115.17% in FY2022 (+62.93 pp) and -178.10% in FY2021 (-1.54 pp).
- The five-year range for quarterly Net Margin is -1861.60% (Q4 2024) to 57.37% (Q3 2025).
- The fastest year-over-year change in Net Margin over five years came in Q4 2025 (a gain of 1095.94 percentage points), and the weakest in Q4 2024 (a drop of 995.84 percentage points).
- Business Quant data shows IDYA's Net Margin at -1502.12% (Q1 2026), -765.66% (Q4 2025) and 57.37% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 21.86% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 21.27% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -8.04% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 22.61% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 18.81% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 23.62% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -134.51% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -1.65% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 32.99% |
| 10 | IDEAYA Biosciences | 3.68 Bn | 757.04 Mn | - | -1,269.64% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1,269.64% |
| Mar 31, 2026 | -1,502.12% |
| Dec 31, 2025 | -765.66% |
| Sep 30, 2025 | 57.37% |
| Dec 31, 2024 | -1,861.60% |
| Dec 31, 2023 | -865.76% |
| Sep 30, 2023 | -341.38% |
| Jun 30, 2023 | -787.98% |
| Mar 31, 2023 | -300.00% |
| Dec 31, 2022 | -601.72% |
| Sep 30, 2022 | 5.44% |
| Jun 30, 2022 | -376.96% |
| Mar 31, 2022 | -123.36% |
| Dec 31, 2021 | -614.85% |
| Sep 30, 2021 | -129.03% |
| Jun 30, 2021 | -125.02% |
| Mar 31, 2021 | -124.48% |
| Dec 31, 2020 | -48.58% |
| Sep 30, 2020 | -54.93% |
API Access
IDEAYA Biosciences Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=IDYA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "IDYA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=IDYA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();